Literature DB >> 26113144

Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.

Hugo J A Adams1, Rutger A J Nievelstein2, Thomas C Kwee2.   

Abstract

Bone marrow involvement in lymphoma may have prognostic and therapeutic consequences. Bone marrow biopsy (BMB) is the established method for the evaluation of the bone marrow. (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) plays an important role in lymphoma staging, but its value in the assessment of the bone marrow and whether it can replace BMB is still a topic of debate and investigation. The purpose of this scientific communication is to provide an evidence-based overview about the opportunities and limitations of BMB and FDG-PET in the evaluation of the bone marrow in patients with lymphoma. This article first reviews the basic properties, opportunities and limitations of BMB and bone marrow FDG-PET, and then focuses on the clinical utility of BMB and bone marrow FDG-PET in three major lymphoma subtypes including Hodgkin lymphoma, diffuse large B-cell lymphoma, and follicular lymphoma.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone marrow; Diffuse large B-cell lymphoma; FDG-PET; Follicular lymphoma; Hodgkin lymphoma

Mesh：

Substances：

Year:  2015        PMID： 26113144     DOI： 10.1016/j.blre.2015.06.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN： 0268-960X            Impact factor:   8.250


  16 in total

1.  Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.

Authors:  Annalisa Balbo-Mussetto; Chiara Saviolo; Alberto Fornari; Daniela Gottardi; Massimo Petracchini; Annalisa Macera; Chiara Valentina Lario; Teresa Gallo; Corrado Tarella; Stefano Cirillo
Journal:  Radiol Med       Date:  2017-04-18       Impact factor: 3.469

2.  68Ga-Pentixafor PET/CT for Imaging of Chemokine Receptor 4 Expression in Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.

Authors:  Yaping Luo; Xinxin Cao; Qingqing Pan; Jian Li; Jun Feng; Fang Li
Journal:  J Nucl Med       Date:  2019-05-17       Impact factor: 10.057

3.  Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.

Authors:  Frédérique St-Pierre; Stephen M Broski; Betsy R LaPlant; Matthew J Maurer; Kay Ristow; Gita Thanarajasingam; William R Macon; Thomas M Habermann; Thomas E Witzig
Journal:  Oncologist       Date:  2020-04-28

4.  Correlation of texture feature analysis with bone marrow infiltration in initial staging of patients with lymphoma using 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography.

Authors:  Mahmoud A Kenawy; Magdy M Khalil; Mahmoud H Abdelgawad; H H El-Bahnasawy
Journal:  Pol J Radiol       Date:  2020-10-19

5.  Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA.

Authors:  Sarah C Rutherford; Michael Herold; Wolfgang Hiddemann; Lale Kostakoglu; Robert Marcus; Maurizio Martelli; Laurie H Sehn; Marek Trněný; Judith Trotman; Umberto Vitolo; Tina Nielsen; Federico Mattiello; Deniz Sahin; Gila Sellam; Peter Martin
Journal:  Blood Adv       Date:  2020-04-28

6.  Comparison of Bone Marrow Involvement with Bone Marrow Biopsy and PET-CT and Evaluation of Any Effects on Survival in Patients Diagnosed with Hodgkin and Non-Hodgkin Lymphoma.

Authors:  Mesut Göçer; Erdal Kurtoğlu
Journal:  Indian J Hematol Blood Transfus       Date:  2020-05-04       Impact factor: 0.900

7.  Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy.

Authors:  Bing Hao; Long Zhao; Na-Na Luo; Dan Ruan; Yi-Zhen Pang; Wei Guo; Hao Fu; Xiu-Yu Guo; Zuo-Ming Luo; Jing Wu; Hao-Jun Chen; Hua Wu; Long Sun
Journal:  BMC Cancer       Date:  2018-11-29       Impact factor: 4.430

8.  Prognostic Value of Bone Marrow F-18 FDG Uptake in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma.

Authors:  Jiyoung Wang; Dongwoo Kim; Won Jun Kang; Hojin Cho
Journal:  Nucl Med Mol Imaging       Date:  2019-12-13

9.  The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma.

Authors:  Chava Perry; Hedva Lerman; Erel Joffe; Nadav Sarid; Odelia Amit; Irit Avivi; Mikhail Kesler; Jonathan Ben-Ezra; Einat Even-Sapir; Yair Herishanu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

10.  Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.

Authors:  Nicolas Aide; Marjolaine Talbot; Christophe Fruchart; Gandhi Damaj; Charline Lasnon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-07       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.